Citizens Jmp Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: Citizens Jmp
Rating: 0
Author: MarketBeat

View the latest stock recommendations issued by analysts at Citizens Jmp. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from Citizens Jmp's equity research team. MarketBeat is not affiliated with or endorsed by Citizens Jmp.

39 Analysts
Updated 9/11/2026

Brokerage Ranking: Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Total Ratings: 989 Last 12 Months
Buy Ratings: 800 Last 12 Months
Sell Ratings: 7 Last 12 Months
Companies Covered: 424 Last 12 Months

Company	Current Price	Report Date	Analyst	Action	Price Target	Rating	Details
ADBE Adobe	$252.23	9/11/2026	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Market Perform	View details for Citizens Jmp rating of Adobe (NASDAQ:ADBE) on 9/11/2026
HOOD Robinhood Markets	$112.57	9/11/2026	Devin Ryan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$155.00 ➝ $165.00	Market Outperform	View details for Citizens Jmp rating of Robinhood Markets (NASDAQ:HOOD) on 9/11/2026
OPEN Opendoor Technologies	$2.79	9/11/2026	Andrew Boone Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Market Perform	View details for Citizens Jmp rating of Opendoor Technologies (NASDAQ:OPEN) on 9/11/2026
AVAV AeroVironment	$146.71	9/10/2026	Trevor Walsh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$230.00	Market Outperform	View details for Citizens Jmp rating of AeroVironment (NASDAQ:AVAV) on 9/10/2026
BOW Bowhead Specialty	$33.71 +0.1%	9/10/2026	Matthew J. Carletti Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform ➝ Market Perform	View details for Citizens Jmp rating of Bowhead Specialty (NYSE:BOW) on 9/10/2026
CHWY Chewy	$20.33 -0.5%	9/10/2026	Andrew Boone Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$28.00	Market Outperform	View details for Citizens Jmp rating of Chewy (NYSE:CHWY) on 9/10/2026
GLOO Gloo	$3.33	9/10/2026	Andrew Boone Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$8.00	Market Outperform	View details for Citizens Jmp rating of Gloo (NASDAQ:GLOO) on 9/10/2026
IRT Independence Realty Trust	$15.24 +0.3%	9/10/2026	Aaron Hecht Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$22.00	Market Outperform	View details for Citizens Jmp rating of Independence Realty Trust (NYSE:IRT) on 9/10/2026
KBH KB Home	$49.11 -0.1%	9/10/2026	James McCanless Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$77.00	Market Outperform	View details for Citizens Jmp rating of KB Home (NYSE:KBH) on 9/10/2026
NAVN Navan	$21.02	9/10/2026	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$38.00	Market Outperform	View details for Citizens Jmp rating of Navan (NASDAQ:NAVN) on 9/10/2026
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
BRZE Braze	$23.94	9/9/2026	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$35.00	Market Outperform	View details for Citizens Jmp rating of Braze (NASDAQ:BRZE) on 9/9/2026
ENGN enGene	$1.80	9/9/2026	Silvan Turkcan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Market Perform	View details for Citizens Jmp rating of enGene (NASDAQ:ENGN) on 9/9/2026
GPCR Structure Therapeutics	$38.66	9/9/2026	Jonathan Wolleben Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$110.00	Market Outperform	View details for Citizens Jmp rating of Structure Therapeutics (NASDAQ:GPCR) on 9/9/2026
NTLA Intellia Therapeutics	$11.74	9/9/2026	Silvan Turkcan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$30.00	Market Outperform	View details for Citizens Jmp rating of Intellia Therapeutics (NASDAQ:NTLA) on 9/9/2026
ORCL Oracle	$150.13 -0.1%	9/9/2026	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$285.00	Market Outperform	View details for Citizens Jmp rating of Oracle (NYSE:ORCL) on 9/9/2026
PHVS Pharvaris	$38.02	9/9/2026	Jonathan Wolleben Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$75.00 ➝ $79.00	Market Outperform	View details for Citizens Jmp rating of Pharvaris (NASDAQ:PHVS) on 9/9/2026
DKNG DraftKings	$24.74	9/8/2026	Jordan Bender Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$36.00 ➝ $37.00	Market Outperform	View details for Citizens Jmp rating of DraftKings (NASDAQ:DKNG) on 9/8/2026
PGNY Progyny	$27.35	9/8/2026	Constantine Davides Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$31.00 ➝ $33.00	Market Outperform	View details for Citizens Jmp rating of Progyny (NASDAQ:PGNY) on 9/8/2026
ASAN Asana	$8.80 +0.4%	9/4/2026	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$15.00	Market Outperform	View details for Citizens Jmp rating of Asana (NYSE:ASAN) on 9/4/2026
DOCU Docusign	$65.65	9/4/2026	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$86.00	Market Outperform	View details for Citizens Jmp rating of Docusign (NASDAQ:DOCU) on 9/4/2026
GWRE Guidewire Software	$140.87 0.0%	9/4/2026	Aaron Kimson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$220.00	Market Outperform	View details for Citizens Jmp rating of Guidewire Software (NYSE:GWRE) on 9/4/2026
PL Planet Labs PBC	$16.47 +0.1%	9/4/2026	Trevor Walsh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Market Perform	View details for Citizens Jmp rating of Planet Labs PBC (NYSE:PL) on 9/4/2026
AI C3.ai	$10.53 -0.1%	9/3/2026	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Market Perform	View details for Citizens Jmp rating of C3.ai (NYSE:AI) on 9/3/2026
SNOW Snowflake	$326.97 -0.6%	9/3/2026	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$408.00 ➝ $488.00	Market Outperform	View details for Citizens Jmp rating of Snowflake (NYSE:SNOW) on 9/3/2026
ENOV Enovis	$19.54 +1.4%	9/2/2026	David Turkaly Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$55.00 ➝ $47.00	Market Outperform	View details for Citizens Jmp rating of Enovis (NYSE:ENOV) on 9/2/2026
MDB MongoDB	$362.21	9/2/2026	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$519.00	Market Outperform	View details for Citizens Jmp rating of MongoDB (NASDAQ:MDB) on 9/2/2026
GTY Getty Realty	$32.26 0.0%	9/1/2026	Mitch Germain Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$39.00	Market Outperform	View details for Citizens Jmp rating of Getty Realty (NYSE:GTY) on 9/1/2026
IDYA IDEAYA Biosciences	$37.59	9/1/2026	Silvan Turkcan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$42.00	Market Outperform	View details for Citizens Jmp rating of IDEAYA Biosciences (NASDAQ:IDYA) on 9/1/2026
CRSP CRISPR Therapeutics	$51.72	8/31/2026	Silvan Turkcan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$80.00	Market Outperform	View details for Citizens Jmp rating of CRISPR Therapeutics (NASDAQ:CRSP) on 8/31/2026
GNL Global Net Lease	$9.06 +0.1%	8/31/2026	Mitch Germain Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$10.00	Market Outperform	View details for Citizens Jmp rating of Global Net Lease (NYSE:GNL) on 8/31/2026
NET Cloudflare	$306.22 -0.1%	8/31/2026	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$394.00	Market Outperform	View details for Citizens Jmp rating of Cloudflare (NYSE:NET) on 8/31/2026
SGHC Super Group (SGHC)	$13.83 0.0%	8/31/2026	Jordan Bender Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$19.00	Market Outperform	View details for Citizens Jmp rating of Super Group (SGHC) (NYSE:SGHC) on 8/31/2026
S SentinelOne	$19.83 +0.4%	8/28/2026	Rustam Kanga Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$23.00 ➝ $25.00	Market Outperform	View details for Citizens Jmp rating of SentinelOne (NYSE:S) on 8/28/2026
CRWD CrowdStrike	$206.74	8/27/2026	Rustam Kanga Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$230.00	Market Outperform	View details for Citizens Jmp rating of CrowdStrike (NASDAQ:CRWD) on 8/27/2026
MIRM Mirum Pharmaceuticals	$98.22	8/27/2026	Jonathan Wolleben Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$137.00	Market Outperform	View details for Citizens Jmp rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 8/27/2026
OKTA Okta	$166.50	8/27/2026	Rustam Kanga Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$170.00 ➝ $180.00	Market Outperform	View details for Citizens Jmp rating of Okta (NASDAQ:OKTA) on 8/27/2026
STXS Stereotaxis	$1.29	8/27/2026	Daniel Stauder Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$4.00 ➝ $3.00	Market Outperform	View details for Citizens Jmp rating of Stereotaxis (NYSEAMERICAN:STXS) on 8/27/2026
TWLO Twilio	$227.32 0.0%	8/27/2026	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$275.00	Market Outperform	View details for Citizens Jmp rating of Twilio (NYSE:TWLO) on 8/27/2026
NCNO nCino	$21.25	8/26/2026	Aaron Kimson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$23.00 ➝ $25.00	Market Outperform	View details for Citizens Jmp rating of nCino (NASDAQ:NCNO) on 8/26/2026
OPFI OppFi	$7.93 -0.6%	8/26/2026	David Scharf Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$11.00	Market Outperform	View details for Citizens Jmp rating of OppFi (NYSE:OPFI) on 8/26/2026
Gold just passed our debt as the world's #1 asset (Ad) China's US Treasury holdings have fallen from a peak of $1.32 trillion to roughly $659 billion, an 18-year low. Beijing's central bank has bought gold for 20 straight months, its longest streak in a decade. Goldman Sachs estimates China's real gold buying is 4.8 times the official figure. The European Central Bank confirms gold has overtaken US Treasuries as the world's top reserve asset, at 27% versus 22%. As foreign demand for US debt fades, rates and everyday costs may feel the pressure. See what's driving the global shift toward gold now
ZM Zoom Communications	$95.57	8/26/2026	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Market Perform	View details for Citizens Jmp rating of Zoom Communications (NASDAQ:ZM) on 8/26/2026
ZYME Zymeworks	$26.24	8/26/2026	Reni Benjamin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$32.00	Market Outperform	View details for Citizens Jmp rating of Zymeworks (NASDAQ:ZYME) on 8/26/2026
CRM Salesforce	$247.41 -0.1%	8/25/2026	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$315.00	Market Outperform	View details for Citizens Jmp rating of Salesforce (NYSE:CRM) on 8/25/2026
CRSP CRISPR Therapeutics	$51.72	8/25/2026	Silvan Turkcan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$80.00	Market Outperform	View details for Citizens Jmp rating of CRISPR Therapeutics (NASDAQ:CRSP) on 8/25/2026
FCPT Four Corners Property Trust	$23.96 -0.1%	8/25/2026	Mitch Germain Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$28.00	Market Outperform	View details for Citizens Jmp rating of Four Corners Property Trust (NYSE:FCPT) on 8/25/2026
NTLA Intellia Therapeutics	$11.74	8/25/2026	Silvan Turkcan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$30.00	Market Outperform	View details for Citizens Jmp rating of Intellia Therapeutics (NASDAQ:NTLA) on 8/25/2026
UBER Uber Technologies	$71.64 0.0%	8/25/2026	Andrew Boone Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$100.00	Market Outperform	View details for Citizens Jmp rating of Uber Technologies (NYSE:UBER) on 8/25/2026
KURA Kura Oncology	$11.39	8/24/2026	Reni Benjamin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$24.00	Market Outperform	View details for Citizens Jmp rating of Kura Oncology (NASDAQ:KURA) on 8/24/2026
BLDR Builders FirstSource	$60.52 +0.2%	8/21/2026	James McCanless Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage		Market Perform	View details for Citizens Jmp rating of Builders FirstSource (NYSE:BLDR) on 8/21/2026
BRT BRT Apartments	$14.14 -0.4%	8/20/2026	Aaron Hecht Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$20.00	Market Outperform	View details for Citizens Jmp rating of BRT Apartments (NYSE:BRT) on 8/20/2026
LIME Neutron	$31.72	8/20/2026	Andrew Boone Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$45.00	Market Outperform	View details for Citizens Jmp rating of Neutron (NASDAQ:LIME) on 8/20/2026
NXRT NexPoint Residential Trust	$22.85 +0.3%	8/20/2026	Aaron Hecht Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Market Perform	View details for Citizens Jmp rating of NexPoint Residential Trust (NYSE:NXRT) on 8/20/2026
MDB MongoDB	$362.21	8/19/2026	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$366.00 ➝ $519.00	Market Outperform	View details for Citizens Jmp rating of MongoDB (NASDAQ:MDB) on 8/19/2026
ARGX argenex	$984.39	8/18/2026	Jason Butler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$932.00 ➝ $1,200.00	Market Outperform	View details for Citizens Jmp rating of argenex (NASDAQ:ARGX) on 8/18/2026
DOCU Docusign	$65.65	8/18/2026	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$86.00	Market Outperform	View details for Citizens Jmp rating of Docusign (NASDAQ:DOCU) on 8/18/2026
HURA TuHURA Biosciences	$2.05	8/18/2026	Silvan Turkcan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$9.00	Market Outperform	View details for Citizens Jmp rating of TuHURA Biosciences (NASDAQ:HURA) on 8/18/2026
SNOW Snowflake	$326.97 -0.6%	8/18/2026	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$325.00 ➝ $408.00	Market Outperform	View details for Citizens Jmp rating of Snowflake (NYSE:SNOW) on 8/18/2026
WD Walker & Dunlop	$40.55 +0.0%	8/18/2026	Chris Muller Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$70.00 ➝ $55.00	Market Outperform	View details for Citizens Jmp rating of Walker & Dunlop (NYSE:WD) on 8/18/2026
ALLO Allogene Therapeutics	$1.78	8/17/2026	Reni Benjamin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$6.00	Market Outperform	View details for Citizens Jmp rating of Allogene Therapeutics (NASDAQ:ALLO) on 8/17/2026
ARE Alexandria Real Estate Equities	$51.13 0.0%	8/17/2026	Aaron Hecht Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Market Perform	View details for Citizens Jmp rating of Alexandria Real Estate Equities (NYSE:ARE) on 8/17/2026
CELC Celcuity	$83.45	8/17/2026	Silvan Turkcan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$177.00	Market Outperform	View details for Citizens Jmp rating of Celcuity (NASDAQ:CELC) on 8/17/2026
DOMO Domo	$3.83	8/17/2026	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$2.25	Market Underperform	View details for Citizens Jmp rating of Domo (NASDAQ:DOMO) on 8/17/2026
LONA Athira Pharma	$6.92	8/17/2026	Jason Butler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$18.00 ➝ $17.00	Market Outperform	View details for Citizens Jmp rating of Athira Pharma (NASDAQ:LONA) on 8/17/2026
AMN AMN Healthcare Services	$33.33 0.0%	8/14/2026	Constantine Davides Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$36.00 ➝ $40.00	Market Outperform	View details for Citizens Jmp rating of AMN Healthcare Services (NYSE:AMN) on 8/14/2026
ARX Accelerant	$19.85 +0.0%	8/14/2026	Matthew J. Carletti Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Market Outperform ➝ Hold	View details for Citizens Jmp rating of Accelerant (NYSE:ARX) on 8/14/2026
JCAP Jernigan Capital	$21.38	8/14/2026	David Scharf Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$26.00 ➝ $28.00	Market Outperform	View details for Citizens Jmp rating of Jernigan Capital (NASDAQ:JCAP) on 8/14/2026
OMDA Omada Health	$19.66	8/14/2026	Constantine Davides Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$27.00 ➝ $32.00	Market Outperform	View details for Citizens Jmp rating of Omada Health (NASDAQ:OMDA) on 8/14/2026
OPRX OptimizeRx	$7.29	8/14/2026	Constantine Davides Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$9.00 ➝ $11.00	Market Outperform	View details for Citizens Jmp rating of OptimizeRx (NASDAQ:OPRX) on 8/14/2026
SGMT Sagimet Biosciences	$10.88	8/14/2026	Jonathan Wolleben Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$12.00 ➝ $29.00	Market Outperform	View details for Citizens Jmp rating of Sagimet Biosciences (NASDAQ:SGMT) on 8/14/2026
SSTI SoundThinking	$5.61	8/14/2026	Trevor Walsh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform ➝ Market Perform	View details for Citizens Jmp rating of SoundThinking (NASDAQ:SSTI) on 8/14/2026
ANNX Annexon	$3.94	8/13/2026	Jonathan Wolleben Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Underperform ➝ Market Perform	View details for Citizens Jmp rating of Annexon (NASDAQ:ANNX) on 8/13/2026
PHVS Pharvaris	$38.02	8/13/2026	Jonathan Wolleben Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$74.00 ➝ $75.00	Market Outperform	View details for Citizens Jmp rating of Pharvaris (NASDAQ:PHVS) on 8/13/2026
PLGO Fidelis Insurance	$25.27 +0.3%	8/13/2026	Matthew J. Carletti Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$28.00 ➝ $29.00	Market Outperform	View details for Citizens Jmp rating of Fidelis Insurance (NYSE:PLGO) on 8/13/2026
SPRB Spruce Biosciences	$53.70	8/13/2026	Jonathan Wolleben Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$150.00 ➝ $144.00	Market Outperform	View details for Citizens Jmp rating of Spruce Biosciences (NASDAQ:SPRB) on 8/13/2026
STRO Sutro Biopharma	$16.86	8/13/2026	Reni Benjamin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$41.00 ➝ $34.00	Market Outperform	View details for Citizens Jmp rating of Sutro Biopharma (NASDAQ:STRO) on 8/13/2026
AII American Integrity Insurance Group	$25.95 +0.1%	8/12/2026	Matthew J. Carletti Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$25.00 ➝ $26.00	Market Outperform	View details for Citizens Jmp rating of American Integrity Insurance Group (NYSE:AII) on 8/12/2026
CRWD CrowdStrike	$206.74	8/12/2026	Rustam Kanga Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$195.00 ➝ $230.00	Market Outperform	View details for Citizens Jmp rating of CrowdStrike (NASDAQ:CRWD) on 8/12/2026
OKTA Okta	$166.50	8/12/2026	Rustam Kanga Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	$170.00	Market Perform ➝ Outperform	View details for Citizens Jmp rating of Okta (NASDAQ:OKTA) on 8/12/2026
PANW Palo Alto Networks	$330.65	8/12/2026	Rustam Kanga Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$320.00 ➝ $415.00	Market Outperform	View details for Citizens Jmp rating of Palo Alto Networks (NASDAQ:PANW) on 8/12/2026
REFI Chicago Atlantic Real Estate Finance	$10.73	8/12/2026	Chris Muller Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$18.00 ➝ $16.00	Market Outperform	View details for Citizens Jmp rating of Chicago Atlantic Real Estate Finance (NASDAQ:REFI) on 8/12/2026
ACVA ACV Auctions	$10.42 +0.0%	8/11/2026		Downgrade		Outperform ➝ Market Perform	View details for Citizens Jmp rating of ACV Auctions (NYSE:ACVA) on 8/11/2026
CHMI Cherry Hill Mortgage Investment	$2.89 +0.5%	8/11/2026	Mikhail Goberman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Market Outperform ➝ Hold	View details for Citizens Jmp rating of Cherry Hill Mortgage Investment (NYSE:CHMI) on 8/11/2026
DSP Viant Technology	$12.58	8/11/2026	Brianna Diaz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$16.00 ➝ $17.00	Market Outperform	View details for Citizens Jmp rating of Viant Technology (NASDAQ:DSP) on 8/11/2026
OPFI OppFi	$7.93 -0.6%	8/11/2026	David Scharf Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$15.00 ➝ $11.00	Market Outperform	View details for Citizens Jmp rating of OppFi (NYSE:OPFI) on 8/11/2026
RKLB Rocket Lab	$62.95	8/11/2026	Trevor Walsh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$130.00	Market Outperform	View details for Citizens Jmp rating of Rocket Lab (NASDAQ:RKLB) on 8/11/2026
SECZ Securitize	$8.29 +0.2%	8/11/2026	Devin Ryan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$15.00	Outperform	View details for Citizens Jmp rating of Securitize (NYSE:SECZ) on 8/11/2026
NHP National Healthcare Properties	$15.74	8/10/2026	Aaron Hecht Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$18.00 ➝ $21.00	Market Outperform	View details for Citizens Jmp rating of National Healthcare Properties (NASDAQ:NHP) on 8/10/2026
RLAY Relay Therapeutics	$18.87	8/10/2026	Silvan Turkcan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$21.00 ➝ $26.00	Market Outperform	View details for Citizens Jmp rating of Relay Therapeutics (NASDAQ:RLAY) on 8/10/2026
SION Sionna Therapeutics	$7.85	8/10/2026	Jonathan Wolleben Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Outperform ➝ Market Perform	View details for Citizens Jmp rating of Sionna Therapeutics (NASDAQ:SION) on 8/10/2026
ABNB Airbnb	$170.19	8/7/2026	Matthew Condon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$170.00 ➝ $190.00	Market Outperform	View details for Citizens Jmp rating of Airbnb (NASDAQ:ABNB) on 8/7/2026
Print this before your next trade (Ad) Bill Poulos is offering his Smart Trade Options Checklist at no cost today - normally priced at $29.97. It's a single-page, seven-point filter designed to help traders identify weak setups before placing any options trade. Print it, keep it at your desk, and run it before every trade. The download link expires soon. Download your free copy of the Smart Trade Options Checklist now
CYTK Cytokinetics	$73.77	8/7/2026	Jason Butler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$105.00 ➝ $110.00	Market Outperform	View details for Citizens Jmp rating of Cytokinetics (NASDAQ:CYTK) on 8/7/2026
DV DoubleVerify	$13.42 +0.0%	8/7/2026	Matthew Condon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Market Outperform ➝ Hold	View details for Citizens Jmp rating of DoubleVerify (NYSE:DV) on 8/7/2026
EXFY Expensify	$2.16	8/7/2026	Aaron Kimson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	$3.00	Market Perform ➝ Outperform	View details for Citizens Jmp rating of Expensify (NASDAQ:EXFY) on 8/7/2026
FLL Full House Resorts	$2.01	8/7/2026	Jordan Bender Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$4.00 ➝ $3.00	Market Outperform	View details for Citizens Jmp rating of Full House Resorts (NASDAQ:FLL) on 8/7/2026
FUN Six Flags Entertainment	$13.17 +0.4%	8/7/2026	Jordan Bender Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$29.00 ➝ $24.00	Market Outperform	View details for Citizens Jmp rating of Six Flags Entertainment (NYSE:FUN) on 8/7/2026
GPCR Structure Therapeutics	$38.66	8/7/2026	Jonathan Wolleben Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$113.00 ➝ $110.00	Market Outperform	View details for Citizens Jmp rating of Structure Therapeutics (NASDAQ:GPCR) on 8/7/2026
HALO Halozyme Therapeutics	$107.20	8/7/2026	Jason Butler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$92.00 ➝ $93.00	Market Outperform	View details for Citizens Jmp rating of Halozyme Therapeutics (NASDAQ:HALO) on 8/7/2026
HCI HCI Group	$185.80 +0.0%	8/7/2026	Matthew J. Carletti Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$255.00 ➝ $265.00	Market Outperform	View details for Citizens Jmp rating of HCI Group (NYSE:HCI) on 8/7/2026
HG Hamilton Insurance Group	$34.83 0.0%	8/7/2026	Matthew J. Carletti Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$40.00 ➝ $42.00	Market Outperform	View details for Citizens Jmp rating of Hamilton Insurance Group (NYSE:HG) on 8/7/2026
IOVA Iovance Biotherapeutics	$8.60	8/7/2026	Reni Benjamin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$5.00 ➝ $8.00	Market Outperform	View details for Citizens Jmp rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 8/7/2026

MarketBeat Community Rating for Citizens Jmp

MarketBeat's community ratings are surveys of what our community members think about Citizens Jmp and other research firms in the last 90 days. Vote "Outperform" if you believe Citizens Jmp's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe Citizens Jmp's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.

COMMUNITY RATINGS: 0.0out of 5 (last 90 days)
0 of 5 stars
OUTPERFORM VOTES: 0 Believe will outperform the market
UNDERPERFORM VOTES: 0 Believe will underperform the market

Analysts at Citizens Jmp

Citizens Jmp's equity research team has issued ratings on 421 companies across 8 sectors over the past 12 months, covered by 39 analysts. The Citizens Jmp analysts below are listed by number of ratings issued in the last year.

Citizens Jmp Stock Coverage by Sector

Citizens Jmp concentrates its research most heavily in Healthcare (25.2%), Finance (21.9%) and Technology (17.7%). The chart below shows how Citizens Jmp's 424 rated companies are distributed across all 8 sectors it covers.

Healthcare
107 companies
25.2%
Finance
93 companies
21.9%
Technology
75 companies
17.7%
Consumer Discretionary
49 companies
11.6%
Industrials
40 companies
9.4%
Real Estate
31 companies
7.3%
Communication Services
24 companies
5.7%
Consumer Staples
2 companies
0.5%

Best & Worst Calls

Best Call
000000.0%
NASDAQ:ABVX
Reiterated Rating • Apr 30, 2025
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
0000.0%
NASDAQ:SYRS
Lower Price Target • Aug 13, 2024
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Similarly Rated Firms

Citizens Jmp - Frequently Asked Questions

Citizens Jmp's analysts currently have buy-equivalent ratings on 349 companies. Recent upgrades to buy include Okta, RXO, Expensify, Essex Property Trust and Athira Pharma.

Citizens Jmp's highest-rated analysts by MarketBeat's accuracy score include Jason Butler, Greg Miller and Jonathan Wolleben. Rankings are based on historical rating accuracy and price target precision over the past 12 months. MarketBeat tracks 43 analysts at Citizens Jmp.

Citizens Jmp has the deepest coverage in Healthcare (25.2% of rated companies), Finance (21.9% of rated companies), Technology (17.7% of rated companies), Consumer Discretionary (11.6% of rated companies) and Industrials (9.4% of rated companies).

Citizens Jmp issued 989 ratings over the last 12 months across 424 companies — an average of roughly 82 rating actions per month. These include boost price target, downgrade, initiated coverage, lower price target, reiterated rating, set price target and upgrade. MarketBeat tracks every rating change as it's published so you can see the most current Citizens Jmp analyst actions.

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?